Erratum: Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111)

Wolfgang Gaebel; Andreas Schreiner; Paul Bergmans; Rosario De Arce; Frédéric Rouillon; Joachim Cordes; Lars Eriksson; Enrico Smeraldi

doi:10.1038/npp.2010.206

Erratum: Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111)

Wolfgang Gaebel, Andreas Schreiner, Paul Bergmans, Rosario De Arce, Frédéric Rouillon, Joachim Cordes, Lars Eriksson, Enrico Smeraldi

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	548
Number of pages	1
Journal	Neuropsychopharmacology
Volume	36
Issue number	2
DOIs	https://doi.org/10.1038/npp.2010.206
Publication status	Published - Jan 2011

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health

Access to Document

10.1038/npp.2010.206

Cite this

Gaebel, W., Schreiner, A., Bergmans, P., Arce, R. D., Rouillon, F., Cordes, J., Eriksson, L., & Smeraldi, E. (2011). Erratum: Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111). Neuropsychopharmacology, 36(2), 548. https://doi.org/10.1038/npp.2010.206

Erratum : Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111). / Gaebel, Wolfgang; Schreiner, Andreas; Bergmans, Paul; Arce, Rosario De; Rouillon, Frédéric; Cordes, Joachim; Eriksson, Lars; Smeraldi, Enrico.

In: Neuropsychopharmacology, Vol. 36, No. 2, 01.2011, p. 548.

Research output: Contribution to journal › Article › peer-review

Gaebel, W, Schreiner, A, Bergmans, P, Arce, RD, Rouillon, F, Cordes, J, Eriksson, L & Smeraldi, E 2011, 'Erratum: Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111)', Neuropsychopharmacology, vol. 36, no. 2, pp. 548. https://doi.org/10.1038/npp.2010.206

Gaebel W, Schreiner A, Bergmans P, Arce RD, Rouillon F, Cordes J et al. Erratum: Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111). Neuropsychopharmacology. 2011 Jan;36(2):548. https://doi.org/10.1038/npp.2010.206

Gaebel, Wolfgang ; Schreiner, Andreas ; Bergmans, Paul ; Arce, Rosario De ; Rouillon, Frédéric ; Cordes, Joachim ; Eriksson, Lars ; Smeraldi, Enrico. / Erratum : Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111). In: Neuropsychopharmacology. 2011 ; Vol. 36, No. 2. pp. 548.

@article{ed9e315ea3254976a92ce5967ead3dd7,

title = "Erratum: Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111)",

author = "Wolfgang Gaebel and Andreas Schreiner and Paul Bergmans and Arce, {Rosario De} and Fr{\'e}d{\'e}ric Rouillon and Joachim Cordes and Lars Eriksson and Enrico Smeraldi",

year = "2011",

month = jan,

doi = "10.1038/npp.2010.206",

language = "English",

volume = "36",

pages = "548",

journal = "Neuropsychopharmacology",

issn = "0893-133X",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Erratum

T2 - Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111)

AU - Gaebel, Wolfgang

AU - Schreiner, Andreas

AU - Bergmans, Paul

AU - Arce, Rosario De

AU - Rouillon, Frédéric

AU - Cordes, Joachim

AU - Eriksson, Lars

AU - Smeraldi, Enrico

PY - 2011/1

Y1 - 2011/1

UR - http://www.scopus.com/inward/record.url?scp=78650173473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650173473&partnerID=8YFLogxK

U2 - 10.1038/npp.2010.206

DO - 10.1038/npp.2010.206

M3 - Article

AN - SCOPUS:78650173473

VL - 36

SP - 548

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 2

ER -

Erratum: Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: Results of a long-term, open-label, randomized clinical trial (Neuropsychopharmacology (2010) 35 (2367-2377) DOI: 10.1038/npp.2010.111)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this